相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
Tsutomu Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade
Kazuyo Kaneko et al.
ARTHRITIS & RHEUMATOLOGY (2016)
The role of tumour-associated macrophages in bone metastasis
Sofia Sousa et al.
JOURNAL OF BONE ONCOLOGY (2016)
Giant cell tumour of bone: new treatments in development
A. Lopez-Pousa et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Viewpoints on vessels and vanishing bones in Gorham-Stout disease
Michael T. Dellinger et al.
BONE (2014)
SH3BP2 Cherubism Mutation Potentiates TNF-α-Induced Osteoclastogenesis via NFATc1 and TNF-α-Mediated Inflammatory Bone Loss
Tomoyuki Mukai et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Rheumatoid arthritis associated with osteopetrosis
Yuho Kadono et al.
Modern Rheumatology (2014)
Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism
Teruhito Yoshitaka et al.
CELL REPORTS (2014)
Anti-tumor necrosis factor treatment in cherubism - Clinical, radiological and histological findings in two children
M. Hero et al.
BONE (2013)
Osteopetrosis: genetics, treatment and new insights into osteoclast function
Cristina Sobacchi et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Forced expression of stabilized c-Fos in dendritic cells reduces cytokine production and immune responses in vivo
Ryoko Yoshida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth
Albert G. Remacle et al.
CANCER RESEARCH (2012)
Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation
Hai Qing et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Georg Schett et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism
Noam Levaot et al.
CELL (2011)
Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties
Chiachien J. Wang et al.
BONE (2010)
Bone remodeling in rheumatic disease: a question of balance
Nicole C. Walsh et al.
IMMUNOLOGICAL REVIEWS (2010)
Membrane-Type I Matrix Metalloproteinase-Dependent Regulation of Rheumatoid Arthritis Synoviocyte Function
Farideh Sabeh et al.
JOURNAL OF IMMUNOLOGY (2010)
Membrane Type 1 Matrix Metalloproteinase Is a Crucial Promoter of Synovial Invasion in Human Rheumatoid Arthritis
Mary-Clare Miller et al.
ARTHRITIS AND RHEUMATISM (2009)
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Laetitia Devy et al.
CANCER RESEARCH (2009)
Osteoimmunology and the effects of the immune system on bone
Hiroshi Takayanagi
NATURE REVIEWS RHEUMATOLOGY (2009)
Bone-Resorbing Cells in Multiple Myeloma: Osteoclasts, Myeloma Cell Polykaryons, or Both?
Franco Silvestris et al.
ONCOLOGIST (2009)
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
Andrea Rubbert-Roth et al.
ARTHRITIS RESEARCH & THERAPY (2009)
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism
Antonios O. Aliprantis et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
c-Fos-deficient mice are susceptible to Salmonella enterica serovar typhimurium infection
Kenta Maruyama et al.
INFECTION AND IMMUNITY (2007)
Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 cherubism mice
Yasuyoshi Ueki et al.
CELL (2007)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP
Yoshifumi Itoh et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Bisphosphonate therapy in rheumatoid arthritis
Veronique Breuil et al.
JOINT BONE SPINE (2006)
c-Fos suppresses systemic inflammatory response to endotoxin
N Ray et al.
INTERNATIONAL IMMUNOLOGY (2006)
Matrix metalloproteinase dependent and independent collagen degradation
Fengyu Song et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
M Asagiri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells
AJ Janckila et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen
P Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling
YJ Wang et al.
JOURNAL OF IMMUNOLOGY (2004)
Bone loss in inflammatory arthritis: mechanisms and treatment strategies
NC Walsh et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation
P Garnero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice
JR Burke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects
XM Dai et al.
BLOOD (2002)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis
AR Pettit et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism
Y Ueki et al.
NATURE GENETICS (2001)
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene
N Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
J Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation
K Matsuo et al.
NATURE GENETICS (2000)